Select your country

24.03.2014
STADA: Successful financial year 2013 – Adjusted EBITDA reaches new record high – Dividend to increase by 32 percent – 2014 outlook adjusted
STADA: Successful financial year 2013 – Adjusted EBITDA reaches new record high – Dividend to increase by 32 percent – 2014 outlook adjusted

STADA: Successful financial year 2013 – Adjusted EBITDA reaches new record high – Dividend to increase by 32 percent – 2014 outlook adjusted…

Read more

03.03.2014
STADA:  Preliminary figures show successful financial year 2013 – Dividend to increase by 32 percent – Outlook for 2014 confirmed
STADA: Preliminary figures show successful financial year 2013 – Dividend to increase by 32 percent – Outlook for 2014 confirmed

STADA: Preliminary figures show successful financial year 2013 – Dividend to increase by 32 percent – Outlook for 2014 confirmed

Read more

28.02.2014
STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throat
STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throat

STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throa…

Read more

14.02.2014
STADA: Local insolvency administrator files lawsuit against a subsidiary of STADA Arzneimittel AG
STADA: Local insolvency administrator files lawsuit against a subsidiary of STADA Arzneimittel AG

STADA: Local insolvency administrator files lawsuit against a subsidiary of STADA Arzneimittel AG

Read more